Global Pre-Sterilized Syringe Market Growth 2025-2031
Description
The global Pre-Sterilized Syringe market size is predicted to grow from US$ 4528 million in 2025 to US$ 6430 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pre-Sterilized Syringe, also called as Pre-filled Syringe, which integrates "storage medicine" and "injection function" into one. Practical and new injection forms are mainly used in vaccines and non-terminally sterilized biological agents.
The Pre-Sterilized Syringe industry concentration is not high; there are more than one hundreds manufacturers in the world, and high-end products mainly from U.S. and Western European.
Global giant manufactures mainly distributed in U.S. and E.U. The manufacturers in U.S. have a long history and unshakable status in this field. Manufacturers such as BD have relative higher level of product’s quality. In Germany, Gerresheimer leads the technology development, it is the world’s second largest player and the No.1 players in Europe. Most of Chinese manufactures locate in Shandong province.
Many companies have several plants, usually locate in the place close to aimed consumption region.
The key consumption markets locate at developed countries. The North America takes the market share of 43.4%, followed by Europe with 28.0%. Asia-Pacific’s consumption market has a quicker growing speed of in the past few years.
LP Information, Inc. (LPI) ' newest research report, the “Pre-Sterilized Syringe Industry Forecast” looks at past sales and reviews total world Pre-Sterilized Syringe sales in 2024, providing a comprehensive analysis by region and market sector of projected Pre-Sterilized Syringe sales for 2025 through 2031. With Pre-Sterilized Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Sterilized Syringe industry.
This Insight Report provides a comprehensive analysis of the global Pre-Sterilized Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Sterilized Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Sterilized Syringe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Sterilized Syringe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Sterilized Syringe.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Sterilized Syringe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Glass Type
Plastic Type
Segmentation by Application:
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other (Beauty, etc.)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Simtra (Baxter)
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
J.O.Pharma
West Pharma
Weigao Group
Shandong Zibo Minkang
Shandong Pharmaceutical Glass
Ningbo Zhengli
Shandong Ujoin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pre-Sterilized Syringe market?
What factors are driving Pre-Sterilized Syringe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pre-Sterilized Syringe market opportunities vary by end market size?
How does Pre-Sterilized Syringe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pre-Sterilized Syringe, also called as Pre-filled Syringe, which integrates "storage medicine" and "injection function" into one. Practical and new injection forms are mainly used in vaccines and non-terminally sterilized biological agents.
The Pre-Sterilized Syringe industry concentration is not high; there are more than one hundreds manufacturers in the world, and high-end products mainly from U.S. and Western European.
Global giant manufactures mainly distributed in U.S. and E.U. The manufacturers in U.S. have a long history and unshakable status in this field. Manufacturers such as BD have relative higher level of product’s quality. In Germany, Gerresheimer leads the technology development, it is the world’s second largest player and the No.1 players in Europe. Most of Chinese manufactures locate in Shandong province.
Many companies have several plants, usually locate in the place close to aimed consumption region.
The key consumption markets locate at developed countries. The North America takes the market share of 43.4%, followed by Europe with 28.0%. Asia-Pacific’s consumption market has a quicker growing speed of in the past few years.
LP Information, Inc. (LPI) ' newest research report, the “Pre-Sterilized Syringe Industry Forecast” looks at past sales and reviews total world Pre-Sterilized Syringe sales in 2024, providing a comprehensive analysis by region and market sector of projected Pre-Sterilized Syringe sales for 2025 through 2031. With Pre-Sterilized Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Sterilized Syringe industry.
This Insight Report provides a comprehensive analysis of the global Pre-Sterilized Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Sterilized Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Sterilized Syringe market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Sterilized Syringe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Sterilized Syringe.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Sterilized Syringe market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Glass Type
Plastic Type
Segmentation by Application:
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other (Beauty, etc.)
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Simtra (Baxter)
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
J.O.Pharma
West Pharma
Weigao Group
Shandong Zibo Minkang
Shandong Pharmaceutical Glass
Ningbo Zhengli
Shandong Ujoin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pre-Sterilized Syringe market?
What factors are driving Pre-Sterilized Syringe market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pre-Sterilized Syringe market opportunities vary by end market size?
How does Pre-Sterilized Syringe break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
142 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Pre-Sterilized Syringe by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Pre-Sterilized Syringe by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
